5Kuo F,GI Llesp IE TA,Kulantha i VEL P. Synthesis andbiologieal activity of some known and putative duloxetine metabotites[J].Bioorg Med Chem Lett, 2004,14 ( 13 ) : 3481.
6Berglund RA.A stereos pecific process for the synthesis of(S) 2(+) 2N,N 2 dimethyl2 32(12 naphthatenyloxy)-3-(2-thienyl) propana- mine,a key intermediate in the synthesis of duloxetine[P].US, US5362886 1994,11:08.
6KUO F, GILLESPIE TA, KULANTHAIVEL P. Synthesis and biological activity of some known and putative duloxetine metabolites[J]. Bioorg Med Chem Lett, 2004, 14(13): 3481 -3486.
7BERGLUND RA. a stereospecific process for the synthesis of ( S ) -( + ) -N, N-dimethyl-3-( 1 -naphthalenyloxy ) -3-( 2-thienyl ) propanamine, a key intermediate in the synthesis of duloxetine: US, US5362886 [ P]. 1994 - 11 -08.
8RAO DR, KANKAN NR, WAIN PC. A process for preparing Duloxetine and intermediates for use therein: India, WO,2004/ 056795 [ P]. 2004 - 07 - 08.
9BERGLUND RA. Impact of potassium salts on aromatic substitution reactions[J]. Org Proc Res Develop, 1997, 1 (4) : 328 - 330.
